Impact of Neoadjuvant Chemotherapy on Postoperative Complications Following Pneumonectomy

Česká verzia

Authors: A. J. Stolz; J. Schützner; T. Haruštiak; R. Lischke ; J. Šimonek; P. Pafko
Authors place of work: III. chirurgická klinika 1. LF UK a FN Praha-Motol, přednosta: prof. MUDr. P. Pafko, DrSc.
Published in the journal: Rozhl. Chir., 2009, roč. 88, č. 5, s. 225-228.
Category: Monothematic special - Original

Summary

Background:
The risks of complications in patients undergoing pneumonectomy after preoperative chemotherapy for nonsmall cell lung cancer remain controversial. We reviewed a consecutive series of patients having undergone pneumonectomy in a single centre.

Material and Methods:
This retrospective study included 292 patients operated from January 1, 1998 through December 31, 2008. Group 1 included patients those who received preoperative chemotherapy and pneumonectmy (57 patients, 19%), and group 2 included patients who underwent pneumonectomy alone (235 patients, 81%). The main objectives were 30-day and 90-day mortality rates, and major postoperative complications.

Results:
There was no statistically significant difference in patients’ age, gender, cardiovascular co morbidity, histology and side of pneumonectomy between these two groups. Overall 30-days and 90-days mortality rates were 5.5 % and 8.6%, respectively. Postoperative mortality at 30 days was 5.2% in group 1 and 5.6 % in group 2 (p = 0.16), and 10.5% for group 1 and 8.1% in group 2 at 90 days (p = 0.8). Incidence of empyema was 5.2 % in group 1 and 3.0 % in group 2 (p = 0.12); incidence of bronchopleural fistula was 3.5 % in group 1 and 3.0% in group 2 (p = 0.10); incidence of postoperative respiratory failure was 3.4% in group 1 and 3.0% in group 2 (p = 0.75).

Conclusion:
Preoperative chemotherapy does not significantly increase postoperative morbidity and early mortality after pneumonectomy in our experience.

Key words:
neoadjuvant chemotherapy – pneumonectomy – morbidity

Zdroje

1. Martin, J., Ginsberg, R. J., Abolhoda, A., et al. Morbidity and mortality after neoadjuvant therapy for lung cancer: the risks of right pneumonectomy. Ann. Thorac. Surg., 2001; 72: l149–1154.

2. Doddoli, C., Barlesi, F., Trousse, D., et al. One hundred consecutive pneumonectomies after induction therapy for non-small cell lung cancer: an uncertain balance between risks and benefits. J. Thorac. Cardiovasc. Surg., 2005; 130: 416–425.

3. Bernard, A., Deschamps, C., Allen, M. S., et al. Pneumonectomy for malignant disease: factors affecting early morbidity and mortality. J. Thorac. Cardiovasc. Surg., 2001; 121: 1076–1082.

4. Roberts, J. R., Eustis, C., Devore, R., et al. Induction chemotherapy increases perioperative complications in patients undergoing resection for non-small cell lung cancer. Ann. Thorac. Surg., 2001 ;72: 885–888.

5. Perrot, E., Guibert, B., Mulsant, P., et al. Preoperative chemotherapy does not increase complications after nonsmall cell lung cancer resection. Ann. Thorac. Surg., 2005; 80: 423–427.

6. Mansour, Z., Kochetkova, E. A., Ducrocq, X., et al. Induction chemotherapy does not increase the operative risk of pneumonectomy! Eur. J. Cardiothorac. Surg., 2007; 31: 181–185.

7. Wyser, C., Stulz, P., Solér, M., et al. Prospective evaluation of an algorithm for the functional assessment of lung resection candidates. Am. J. Respir. Crit. Care Med., 1999; 159: 1450–1456.

8. Leo, F., Solli, P., Veronesi, G., et al. Does chemotherapy increase the risk of respiratory complications after pneumonectomy? J. Thorac. Cardiovasc. Surg., 2006; 132: 519–523.

9. Allen, A. M., Mentzer, S. J., Yeap, B. Y., et al. Pneumonectomy after chemoradiation: the Dana-Farber Cancer Institute/Brigham and Women‘s Hospital experience. Cancer, 2008; 112: 1106–1113.

10. van Schil, P., van Meerbeeck, J., Kramer, G., et al. Morbidity and mortality in the surgery arm of EORTC 08941 trial. Eur. Respir. J., 2005; 26: 192–197.

11. Bernard, A., Deschamps, C., Allen, M. S., et al. Pneumonectomy for malignant disease: factors affecting early morbidity and mortality. J. Thorac. Cardiovasc. Surg., 2001; 121: 1076–1082.